Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
52,265,866
-
Total 13F shares
-
22,099,043
-
Share change
-
+832,830
-
Total reported value
-
$65,215,225
-
Price per share
-
$2.95
-
Number of holders
-
83
-
Value change
-
+$564,356
-
Number of buys
-
42
-
Number of sells
-
36
Institutional Holders of ENZO BIOCHEM INC - Common Stock (ENZB) as of Q1 2015
As of 31 Mar 2015,
ENZO BIOCHEM INC - Common Stock (ENZB) was held by
83 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,099,043 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, DIMENSIONAL FUND ADVISORS LP, BlackRock Institutional Trust Company, N.A., First Light Asset Management, LLC, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, THOMSON HORSTMANN & BRYANT INC, BlackRock Fund Advisors, MANUFACTURERS LIFE INSURANCE COMPANY, THE, and Allianz Asset Management AG.
This page lists
83
institutional shareholders reporting positions in this security
for the Q1 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.